ERBB2 and invasive lobular breast carcinoma: According to our knowledge and most current literature data, this is the first study to provide comprehensive molecular data on HER2‐positive invasive lobular carcinoma and demonstrating that CDK12/HER2 gene coamplification is a common underlying mechanism in this subgroup.